Author: Funaro, Ada; Gribaudo, Giorgio; Luganini, Anna; Ortolan, Erika; Lo Buono, Nicola; Vicenzi, Elisa; Cassetta, Luca; Landolfo, Santo; Buick, Richard; Falciola, Luca; Murphy, Marianne; Garotta, Gianni; Malavasi, Fabio
Title: Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells Document date: 2008_11_12
ID: 1u2fkwx3_18
Snippet: The broad and robust neutralizing activity of mAb 26A1 encouraged us to generate recombinant IgG suitable as prophylactic or therapeutic tools in clinical applications. To this aim, cells were submitted for 5' RACE PCR amplification, the PCR products of two amplification reactions were cloned using a Eco RI restriction site in a sequencing vector and used for transforming TOP10 E. coli. A single VH and VL sequence was obtained from each cell cult.....
Document: The broad and robust neutralizing activity of mAb 26A1 encouraged us to generate recombinant IgG suitable as prophylactic or therapeutic tools in clinical applications. To this aim, cells were submitted for 5' RACE PCR amplification, the PCR products of two amplification reactions were cloned using a Eco RI restriction site in a sequencing vector and used for transforming TOP10 E. coli. A single VH and VL sequence was obtained from each cell culture, confirming that each original culture was clonal ( Figure 4 ).
Search related documents:
Co phrase search for related documents- amplification reaction and clinical application: 1, 2
- amplification reaction and PCR amplification: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amplification reaction and PCR product: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- amplification reaction and race PCR amplification: 1
- amplification reaction and sequence vector: 1
- amplification reaction PCR product and PCR amplification: 1, 2, 3, 4
- amplification reaction PCR product and PCR product: 1, 2, 3, 4
- amplification reaction PCR product and sequence vector: 1
- cell culture and clinical application: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- cell culture and neutralizing activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- cell culture and original culture: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- cell culture and PCR amplification: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell culture and PCR product: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- cell culture and restriction site: 1
- cell culture and sequence vector: 1
- cell culture and TOP10 coli: 1
- clinical application and neutralizing activity: 1, 2, 3
- clinical application and PCR amplification: 1, 2, 3, 4, 5, 6, 7, 8, 9
- clinical application and PCR product: 1, 2
Co phrase search for related documents, hyperlinks ordered by date